207 related articles for article (PubMed ID: 35747187)
21. Antenatal corticosteroids for late-preterm infants: a decision-analytic and economic analysis.
Bastek JA; Langmuir H; Kondapalli LA; Paré E; Adamczak JE; Srinivas SK
ISRN Obstet Gynecol; 2012; 2012():491595. PubMed ID: 23326677
[TBL] [Abstract][Full Text] [Related]
22. The World Health Organization ACTION-I (Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns) Trial: a multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries.
WHO ACTION Trials Collaborators
Trials; 2019 Aug; 20(1):507. PubMed ID: 31420064
[TBL] [Abstract][Full Text] [Related]
23. Tocolysis and preterm labour.
King JF
Curr Opin Obstet Gynecol; 2004 Dec; 16(6):459-63. PubMed ID: 15534440
[TBL] [Abstract][Full Text] [Related]
24. Tocolytic treatment for the management of preterm labour: a systematic review.
Tan TC; Devendra K; Tan LK; Tan HK
Singapore Med J; 2006 May; 47(5):361-6. PubMed ID: 16645683
[TBL] [Abstract][Full Text] [Related]
25. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
[TBL] [Abstract][Full Text] [Related]
26. Oxytocin receptor antagonists for inhibiting preterm labour.
Papatsonis D; Flenady V; Cole S; Liley H
Cochrane Database Syst Rev; 2005 Jul; (3):CD004452. PubMed ID: 16034931
[TBL] [Abstract][Full Text] [Related]
27. Antenatal Corticosteroids for Women at Risk of Imminent Preterm Birth in 7 sub-Saharan African Countries: A Policy and Implementation Landscape Analysis.
Greensides D; Robb-McCord J; Noriega A; Litch JA
Glob Health Sci Pract; 2018 Dec; 6(4):644-656. PubMed ID: 30573455
[TBL] [Abstract][Full Text] [Related]
28. Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial).
van Vliet EO; Schuit E; Heida KY; Opmeer BC; Kok M; Gyselaers W; Porath MM; Woiski M; Bax CJ; Bloemenkamp KW; Scheepers HC; Jaquemyn Y; van Beek E; Duvekot HJ; Franssen MT; Bijvank BN; Kok JH; Franx A; Mol BW; Oudijk MA
BMC Pregnancy Childbirth; 2014 Mar; 14():93. PubMed ID: 24589124
[TBL] [Abstract][Full Text] [Related]
29. Tocolytic Therapy Inhibiting Preterm Birth in High-Risk Populations: A Systematic Review and Meta-Analysis.
Yamaji N; Suzuki H; Saito K; Swa T; Namba F; Vogel JP; Ramson JA; Cao J; Tina L; Ota E
Children (Basel); 2023 Feb; 10(3):. PubMed ID: 36980001
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide donors for treating preterm labour.
Duckitt K; Thornton S; O'Donovan OP; Dowswell T
Cochrane Database Syst Rev; 2014 May; 2014(5):CD002860. PubMed ID: 24809331
[TBL] [Abstract][Full Text] [Related]
31. Costs and economic evaluations of Quality Improvement Collaboratives in healthcare: a systematic review.
de la Perrelle L; Radisic G; Cations M; Kaambwa B; Barbery G; Laver K
BMC Health Serv Res; 2020 Mar; 20(1):155. PubMed ID: 32122378
[TBL] [Abstract][Full Text] [Related]
32. Predicting preterm birth: a cost-effectiveness analysis.
Mozurkewich EL; Naglie G; Krahn MD; Hayashi RH
Am J Obstet Gynecol; 2000 Jun; 182(6):1589-98. PubMed ID: 10871482
[TBL] [Abstract][Full Text] [Related]
33. Prevention of spontaneous preterm birth: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF).
Sentilhes L; Sénat MV; Ancel PY; Azria E; Benoist G; Blanc J; Brabant G; Bretelle F; Brun S; Doret M; Ducroux-Schouwey C; Evrard A; Kayem G; Maisonneuve E; Marcellin L; Marret S; Mottet N; Paysant S; Riethmuller D; Rozenberg P; Schmitz T; Torchin H; Langer B
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():217-224. PubMed ID: 28068594
[TBL] [Abstract][Full Text] [Related]
34. No. 376-Magnesium Sulphate for Fetal Neuroprotection.
Magee LA; De Silva DA; Sawchuck D; Synnes A; von Dadelszen P
J Obstet Gynaecol Can; 2019 Apr; 41(4):505-522. PubMed ID: 30879485
[TBL] [Abstract][Full Text] [Related]
35. Cyclo-oxygenase (COX) inhibitors for treating preterm labour.
King J; Flenady V; Cole S; Thornton S
Cochrane Database Syst Rev; 2005 Apr; (2):CD001992. PubMed ID: 15846626
[TBL] [Abstract][Full Text] [Related]
36. Preterm labour and birth: a survey of clinical practice regarding use of tocolytics, antenatal corticosteroids, and progesterone.
Hui D; Liu G; Kavuma E; Hewson SA; McKay D; Hannah ME
J Obstet Gynaecol Can; 2007 Feb; 29(2):117-124. PubMed ID: 17346482
[TBL] [Abstract][Full Text] [Related]
37. Calcium channel blockers for inhibiting preterm labour.
King JF; Flenady VJ; Papatsonis DN; Dekker GA; Carbonne B
Cochrane Database Syst Rev; 2002; (2):CD002255. PubMed ID: 12076443
[TBL] [Abstract][Full Text] [Related]
38. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials.
Berghella V; Saccone G
Am J Obstet Gynecol; 2016 Oct; 215(4):431-8. PubMed ID: 27133012
[TBL] [Abstract][Full Text] [Related]
39. Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial).
Roos C; Scheepers LH; Bloemenkamp KW; Bolte A; Cornette J; Derks JB; Duvekot HJ; van Eyck J; Kok JH; Kwee A; Merién A; Opmeer BC; van Pampus MG; Papatsonis DN; Porath MM; van der Post JA; Scherjon SA; Sollie K; Spaanderman ME; Vijgen SM; Willekes C; Mol BW; Lotgering FK
BMC Pregnancy Childbirth; 2009 Sep; 9():42. PubMed ID: 19737426
[TBL] [Abstract][Full Text] [Related]
40. Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation.
Wex J; Connolly M; Rath W
BMC Pregnancy Childbirth; 2009 Jun; 9():23. PubMed ID: 19538754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
